These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1088 related items for PubMed ID: 28098858
21. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Zhou W, Zou B, Liu L, Cui K, Gao J, Yuan S, Cong N. Oncotarget; 2016 Nov 08; 7(45):74059-74073. PubMed ID: 27677076 [Abstract] [Full Text] [Related]
22. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C, Guo F, Xu G, Ma J, Shao F. Oncol Rep; 2015 Apr 08; 33(4):1872-82. PubMed ID: 25653024 [Abstract] [Full Text] [Related]
23. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z. Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096 [Abstract] [Full Text] [Related]
24. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z. Biomed Pharmacother; 2017 Apr 05; 88():421-429. PubMed ID: 28122307 [Abstract] [Full Text] [Related]
25. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma. Wang Y, Sun B, Zhao X, Zhao N, Sun R, Zhu D, Zhang Y, Li Y, Gu Q, Dong X, Wang M, An J. Oncotarget; 2016 Apr 26; 7(17):24383-401. PubMed ID: 27027434 [Abstract] [Full Text] [Related]
26. Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8/STAT3-driven hepatocellular carcinoma metastasis. Peng S, Chen Y, Li T, Mao J, Yang P, Zou B, Luo L, Zhang W, Wang W, Xie R, Li J, Zeng L. Cancer Sci; 2022 Dec 26; 113(12):4120-4134. PubMed ID: 36083239 [Abstract] [Full Text] [Related]
28. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X. Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408 [Abstract] [Full Text] [Related]
29. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y, Chen G, Yan Y, Fan Q. Eur J Pharmacol; 2019 Oct 05; 860():172589. PubMed ID: 31401158 [Abstract] [Full Text] [Related]
30. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. Zhang QY, Men CJ, Ding XW. J Cell Biochem; 2019 Sep 05; 120(9):14885-14898. PubMed ID: 31044454 [Abstract] [Full Text] [Related]
31. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Zhou SJ, Liu FY, Zhang AH, Liang HF, Wang Y, Ma R, Jiang YH, Sun NF. Br J Cancer; 2017 Jul 11; 117(2):233-244. PubMed ID: 28588321 [Abstract] [Full Text] [Related]
32. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X. Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241 [Abstract] [Full Text] [Related]
33. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP. Oncotarget; 2016 Apr 19; 7(16):22674-86. PubMed ID: 26993767 [Abstract] [Full Text] [Related]
34. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH. Cancer Lett; 2016 May 28; 375(1):73-83. PubMed ID: 26944318 [Abstract] [Full Text] [Related]
35. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G, Lin Y, Zhang H, Wu D. Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123 [Abstract] [Full Text] [Related]
36. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092 [Abstract] [Full Text] [Related]
37. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma. Huang B, Huang M, Li Q. Pathol Res Pract; 2018 Dec 07; 214(12):1980-1986. PubMed ID: 30274685 [Abstract] [Full Text] [Related]
38. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4. Zhu MX, Wei CY, Zhang PF, Gao DM, Chen J, Zhao Y, Dong SS, Liu BB. J Exp Clin Cancer Res; 2019 Sep 18; 38(1):409. PubMed ID: 31533816 [Abstract] [Full Text] [Related]
39. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X. J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948 [Abstract] [Full Text] [Related]
40. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y, Du J, Liu Z, Zhang D, Yao X, Yang Y. J Exp Clin Cancer Res; 2019 Jan 08; 38(1):7. PubMed ID: 30621734 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]